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It is now recognized that  angiogenesis,  the induction  of capillary proliferation,  is 
important for the continued  growth of solid tumors (1-3). Kessler et al.  (4)  reported 
that mast cells assemble at a tumor site before the ingrowth of new capillaries; it was 
proposed that  mast cells may play a  role in tumor angiogenesis.  Mast cells are also 
found in increased  numbers in other pathologic states associated with angiogenesis, 
such  as psoriasis  (5,  6), chronic  inflammation  (7, 8),  and  immune rejection  (9,  10). 
However, the exact function of the mast cells in angiogenesis is not understood. 
Previously, Ausprunk  and  Folkman  (11)  reported  that  capillary endothelial  cell 
migration  was one of the  major components  of the  growing capillary sprouts  that 
arise in angiogenesis. After bovine capillary endothelial cells were cloned and carried 
in long-term culture (12)  in this laboratory, Zetter (13) developed a quantitative assay 
in  vitro  for measuring  the  migration  of these  cells.  In  this  assay, bovine capillary 
endothelial cells were plated sparsely on glass cover slips coated with colloidal gold so 
that  their  migration  generated  a  phagokinetic  track,  the  area  of which  could  be 
measured accurately. 
We now report that mast cells release a factor that stimulates migration of capillary 
endothelial  cells.  We have investigated  the  effect of isolated  mast cell  products  on 
bovine capillary endothelial  cell migration, and we demonstrate that  heparin is the 
mast cell factor responsible for capillary endothelial cell migration in vitro. 
Materials and Methods 
Assay for Endothelial Cell Migration.  3,000 cells (bovine capillary endothelial, MDCK,  Swiss 
3T3, human fibroblast, or bovine aortic endothelial cells) were seeded onto 22-mm  ~ glass cover 
slips (Rochester Scientific Co.,  Rochester, N.  Y.)  that were coated with colloidal gold,  which 
was  prepared  according  to  the  method  of Albrecht-Buehler  (14,  15).  The  cover  slips  were 
incubated  in  tissue  culture dishes  containing  1 ml of Dulbecco's modified Eagle's medium 
(DMEM) 1 (Gihco Laboratories, Grand Island Biological  Co., Grand Island, N. Y.) with  10% 
calf serum (Gibco Laboratories, Grand Island Biological Co.) at 37°C and 5% CO2. After the 
cells had attached (~2-4 h later), 1 additional ml of conditioned medium (CM) or test medium 
was added. All media contained a final concentration of 10% calf serum (10% CS). The cultures 
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were then incubated for an additional 18 h and the experiment was terminated by replacement 
of the medium with 2 ml of 10% buffered formalin phosphate (Fisher Scientific Co., Pittsburgh, 
Pa.). Cells that moved cleared the colloidal gold in their path and left a track. The phagokinetic 
track images were projected from an inverted microscope (4  ×  objective) to the screen of a 
Setchell-Carson 10M915  television by means of an RCA TC1005 video camera (RCA Labo- 
ratories, Princeton, N.J.) The images were traced onto sheets of transparent plastic. The areas 
of these  phagokinetic tracks were then measured on a  Zeiss  MOP-3 digital image analyzer 
(Carl Zeiss, Inc., New York).  To eliminate consideration of the infrequent cell division or cell 
collisions, only tracks formed by single cells were analyzed. Each point on a graph represents 
the mean area of 100 migration tracks +_ SEM.  For a complete description of this assay see 
Zetter (13). 
Preparation of Mast Cell CM and Lysates.  Mast cells were obtained by lavaging the peritoneal 
cavities of 200-g Sprague-Dawley rats with Hanks' balanced salt solution without heparin. The 
cells were purified on a 38% wt/vol bovine albumin gradient using the method of Sullivan et 
al. (16). An aliquot of a concentrated suspension of the cells was stained with 0.1% toluidine 
blue and counted with a  hemocytometer. Approximately 2.5  ×  106 mast cells/rat could be 
harvested,  with  purity ranging from  85  to  95%. Contaminant cells  included erythrocytes, 
lymphocytes, and occasional macrophages. Mast cell viability after purification as ascertained 
by trypan blue exclusion was 96-99%. The mast cells were isolated from two to four rats for 
each experiment. 5 ml of DMEM 10% CS that contain 1 ×  105 cells/ml were added to a 25-cm  2 
Falcon  flask  (Falcon  Labware,  Div.  of  Becton,  Dickinson  &  Co.,  Oxnard,  Calif.).  After 
incubation for 36 h at 37°C and 5% CO2,  ~25-30% of the mast cells had degranulated. The 
mast cell CM was then removed, filtered through a 0.22-p,m Millipore filter (Millipore Corp., 
Bedford, Mass.)  to remove any cellular debris, and stored at -20°C for up to 1 mo before use. 
Mast cell lysates were prepared by sonicating 1-ml suspensions that contain 1 ×  106 mast cells 
for three pulses of 15 s each at 50 W  (Ultrasonic Instruments International, Westbury, N. Y.). 
The lysed cells were then diluted with 9 ml of DMEM 10% CS and filtered through a 0.22-/tm 
Millipore filter before use. 
Cell  Culture and  Preparation of Sarcoma 180  and  37"3  CM.  Bovine aortic  (17) and  bovine 
capillary endothelial cell (12, 13) cultures were grown and maintained as previously described. 
Bovine capillary endothelial cell (BCE) passages 6-14 were used for the experiments. 4 h before 
use, the growth medium was replaced with fresh DMEM 10% CS without tumor CM. Sarcoma 
180, canine kidney (MDCK), BALB/c 3T3, and Swiss 3T3 cells, and human fibroblasts from 
foreskin explants were grown in DMEM 10% CS supplemented with penicillin (100 U/ml) and 
streptomycin (100 p.g/ml). 
The source of tumor CM was a culture of confluent sarcoma 180 cells as described previously 
(12). To provide 3T3 CM, confluent Swiss 3T3 cells were grown in 75-cm  s Falcon tissue culture 
flasks and incubated in fresh  DMEM  10% CS for 48 h. Approximately 1 ×  108 sarcoma  180 
cells  and 6  ×  105 Swiss  3T3 cells  each conditioned 1 ml of medium. The CM  was passed 
through a 0.22-#m Millipore filter before use. 
BCE Cell Proliferation Experiment.  10,000 capillary endothelial cells (passage  10) were plated 
on 30-mm Falcon tissue culture dishes  in DMEM  10% CS. Plating efficiency of these sparsely 
plated cells was >90%. After 2 h, the cells had attached, and the medium was replaced with 2 
ml of one of the following: mast cell CM, sarcoma  180 CM, or DMEM  10% CS. Cells were 
refed with test  media every 48 h until the sarcoma 180 CM cultures reached confluency at  I0 
d.  Cells were counted on days  7 and  10 using a  Coulter counter (Coulter Electronics Inc., 
Hialeah, Fla.). Each point on the graph represents the mean of three samples ",- SEM. 
BALB/c 3T3 DNA Synthesis Experiment.  Preparation of quiescent cultures of BALB/c 3T3 
cells and the methods for measuring DNA synthesis after treatment with factors have been 
previously published (18). Mast cell CM was tested for effects on growth of 3T3 cells. 
Isolated Mast Cell Products and Glycosaminoglycans Tested for Endothelial Migration Activity.  Each 
of the following mast cell products and glycosaminoglycans (GAG)  was dissolved in DMEM 
supplemented with  10%  CS  and  tested  in  log  concentrations from  10  ng to  1 mg/ml:  5- 
hydroxytryptamine hydrochloride (Sigma Chemical Co., St. Louis, Mo.), bovine trypsin type 
III (Sigma Chemical Co.); bovine pancreas chymotrypsin (Miles Laboratories, Inc., Elkhart, 
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heparin,  grade  1 sodium  salt  derived  from  porcine  intestinal  mucosa  (165  U/mg  [Sigma 
Chemical Co.]); heparin derived from beef lung (183 U/mg [gift of M. B. Mat thews, University 
of Chicago,  Chicago,  Ill.I); chondroitin  sulfate A, special grade  (Miles Laboratories Inc.); 
chondroitin sulfate B  (dermatan sulfate [Sigma Chemical Co.]); chondroitin sulfate C, special 
grade  (Miles Laboratories Inc.);  chondroitin  sulfate mixed  isomers  (Sigma Chemical  Co.); 
hyaluronic acid, grade III (Sigma Chemical Co.); heparan sulfate and keratan sulfate (gifts of 
M. B. Matthews). 
Other Substances Tested for Endothelial Migration Activity.  Dextran sulfate 40,000 and 500,000 
mol wt, dextran 40,000 and 500,000 mol wt, and protamine sulfate (all obtained from Sigma 
Chemical Co.) were dissolved in DMEM supplemented with  10% CS and tested in the same 
range of concentrations as for the experiments above. 
Determination of Heat Stability and Diatyzability  of Mast Cell Medium.  Aliquots of mast cell CM 
were heated in H20 baths for 5 min at temperatures from 37 to 100°C. The mast cell CM was 
also dialyzed exhaustively against DMEM in Spectrapor dialysis tubing (Fisher Scientific Co.) 
with a molecular weight cutoff of 6,000-8,000. 
Incubation of Mast Cell Lysates in Proteolytic Enzymes.  A suspension of 1 ×  106 mast cells (0.39 
mg Lowry protein)  (19)  in  1 ml of H~O was sonicated at 50 W  for three pulses of 15 s each 
(Ultrasonic Instruments International). A  200-#1 aliquot was diluted to 2  ml with  DMEM 
without serum and incubated with 100 mg ofEnzite protease (0.0064 U/mg; Miles Laboratories 
Inc.). The incubation was carried out at 37°C and pH 7.0 for 4 h on a rotating shaker (Aurther 
H.  Thomas  Co.,  Philadelphia,  Pa.).  The  immobilized protease was  then  removed  by  two 
sequential centrifugations at  1,000 g for 5 min. The supernate was filtered through a 0.22-~m 
Millipore filter to insure complete removal of the immobilized enzyme. The same procedure 
was carried out with Enzite trypsin (0.64 U/mg; Miles Laboratories Inc.) at 37°C and pH 8.0 
for 4 h. The control samples for this experiment were processed without enzymes in the same 
manner.  Each  sample was  supplemented  with  10%  CS  and  tested on  the endothelial cell 
migration  assay.  To  verify  the  proteolytic activity of these  enzymes  under  the  identical 
incubation conditions, we labeled confluent BALB/c 3T3 cells in 75-cm  2 flasks with [SH]lysine 
(5  mCi/ml;  New  England  Nuclear,  Boston,  Mass.)  for 48  h.  The  cells were harvested and 
dialyzed exhaustively against glass-distilled water to lyse cells and to remove unincorporated 
[SH]lysine. The cell lysates were washed with phosphate-buffered saline and centrifuged. The 
supernate was decanted and the cellular material suspended in 3 ml DMEM without serum. 
Aliquots (500 #1) of this suspension were incubated alone or with Enzite protease (50 mg/ml) 
or Enzite trypsin (25 mg/ml). After incubation and removal of the immobilized enzymes, the 
samples were precipitated with trichloracetic acid (TCA) to a final concentration of 5% TCA. 
The samples were placed on individual type HA filters (Millipore Corp.) and washed with 5% 
TCA and ethanol. The filters were placed in Instagel (Packard Instrument Co., Inc., Downers 
Grove, Ill.) and counted on a Packard scintillation counter for 10 min. 
Heparinase and Chondroitinase ABC  Treatment of CM.  Crude heparinase was prepared from 
Flavobacterium heparinum (gift ofJ. E. Silbert, Boston Veterans Administration Hospital, Boston, 
Mass.). 20 mg of lyophilized bacteria, suspended in 1 ml of H20, was sonieated at 50 W  for six 
pulses of 15 s each (Ultrasonic Instruments International). The suspension was centrifuged at 
1,000 g for 10 min to remove bacterial debris. A 200-#1 aliquot of crude heparinase solution was 
incubated at 35°C, pH 7.0, for 12 h with 1,800 #1 of the following: mast cell CM, sarcoma 180 
CM, DMEM  10% CS, and DMEM  10% CS supplemented with heparin (50 #g/ml, grade  1 
sodium salt, 167 U/mg; Sigma Chemical Co.).  100 #1 of this enzyme preparation neutralized 
the anticoagulant activity of 600 #g (~ 100 U) of heparin in 3 ml of fresh whole blood. There 
was no detectable protease activity (< 1 #g/ml) in the heparinase preparation as measured by 
the method of Schill and Schumacher (20). 
Chondroitinase ABC (0.5  U/ml;  Miles Laboratories Inc.) was incubated at 37°C,  pH  7.4, 
for 12 h with the following: mast cell CM, sarcoma CM, DMEM  10% CS supplemented with 
heparin  (50 #g/ml),  or DMEM  10%  CS.  The  heparinase and  chondroitinase ABC-treated 
samples  and  the  non-enzyme-treated  controls  were  assayed  for  endothelial  cell  migration 
activity. 
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within an experiment. In addition, the Student-Newman-Keuls multiple range test was used to 
determine between which means there were significant  differences  (C.L. -->0.95). 
Results 
Mast  cell CM  caused significant  increases  in  BCE  migration  in  vitro  (P <  0.01) 
(Fig.  1). As reported previously, endothelial cell phagokinetic track size was directly 
proportional  to the area of migration  (13).  In repeated  18-h experiments, mast cell 
CM resulted in a  mean increase in phagokinetic track size of >10,000/tm2/cell.  This 
increase was 100-120% greater than the area of controls that were incubated in either 
DMEM  10%  CS  alone  or  in  Swiss  3T3  CM  (Fig.  1 E).  The  increase  in  capillary 
endothelial cell migration in response to sarcoma 180 CM and mast cell CM were not 
significantly different  (P ~  0.05)  (Fig.  1 E). The stimulation of capillary endothelial 
cell migration by mast cell CM was dose-dependent. When the concentration of mast 
cell CM was increased from 0-100%, a progressive increase in BCE cell migration was 
observed (Fig. 2). In addition, mast cell lysates and mast cell CM equally stimulated 
capillary endothelial cell migration. 
To control for the specificity of the mast cell effect upon capillary endothelial cells, 
we examined the migration of four additional cell types incubated in mast cell CM: 
bovine  aortic  endothelial,  Swiss  3T3,  canine  kidney  cells  (MDCK),  and  human 
Ftg.  1.  Migration of BCE in response to media conditioned by sarcoma 180, mast, and 3T3 cells. 
Test  media:  (A)  DMEM  10%  CS  not  conditioned;  (B)  DMEM  10%  diluted  1:2  with  the  same 
medium conditioned  by  3T3  cells;  (C)  sarcoma  180  cells;  (D)  mast cells.  BCE were seeded  at  a 
concentration of 3,000  cells  in  1 ml DMEM  10% CS onto coverslips coated with colloidal gold. (E) 
After  18  h, cells  were fixed with  10%  formalin in  phosphate-buffered saline, and  the area of the 
phagokinetic tracks was measured with the aid of a Zeiss MOP-3 digital image analyser as described 
in Materials and Methods. Each bar represents the area of 100 tracks 4- SEM. R. AZIZKHAN, J.  AZIZKHAN, B.  ZETTER,  AND J.  FOLKMAN 
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F=o.  2.  The effect of mast cell CM on the migration of BCE bovine aortic endothelial cells (BAE), 
and Swiss 3T3 cells. Using the method described in the legend to Fig. l, concentrations of mast cell 
CM from 0 to 100% were incubated with BCE (O), BAE (0), and 3T3 cells (A). Each point on the 
graph represents the mean area of 100 phagokinctic tracks + SEM. 
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fibroblasts  grown  from  foreskin explants.  When  compared with  DMEM  10%  CS, 
mast cell CM did not alter the migration of aortic endothelial  cells (Fig.  2), canine 
kidney (MDCK) cells, or human fibroblasts (data not shown).  Swiss 3T3 cell migra- 
tion,  however,  was  progressively  inhibited  as  the  percent  of  mast  cell  CM  was 
increased (Fig. 2). 
Effect  of Mast  Cell  CM on  Proliferation.  Many  factors stimulating  migration  also 
stimulate proliferation of endothelial cells (13, 21). We found that mast cell CM did 
not enhance capillary endothelial cell proliferation over levels achieved with DMEM 
supplemented with  10% CS (P_> 0.05)  (Fig. 3). On the other hand, sarcoma 180 CM, 
which is known to be mitogenic for capillary endothelial cells (12), stimulated a 500% 
increase in cell number compared with mast cell CM or DMEM  10% CS (P <  0.01). 
This experiment  was repeated  three  times with  nearly identical  results.  To further 
evaluate possible mast cell mitogenicity, the effect of mast cell CM on DNA synthesis 
by quiescent BALB/c 3T3 cells was also investigated. Mast cell CM had no effect on 
basal  incorporation  of  [3H]thymidine  but,  when  added  together  with  serum,  it 
inhibited the stimulation of DNA synthesis by serum (Fig. 4). 
Effect  of Mast  Cell  Products on  Capillary Endothelial  Cell  Migration.  To  determine 
whether endothelial cell migration activity could be assigned to a particular mast cell 
product,  the effect of the  following mast cell products on capillary endothelial  cell 
migration  was  examined:  heparin,  histamine,  ECF-A,  chondroitin  sulfate  (mixed 
isomers) (Fig. 5), 5-hydroxytryptamine, chondroitin sulfates A, B, and C, trypsin, and 
chymotrypsin (data not shown). These substances were tested in log increments over 
a  concentration  range  of  10  ng-1  mg/ml.  Only  heparin  significantly  stimulated 
capillary endothelial cell migration (P <  0.01)  (Fig. 5). Increased migration could be 
observed with as little heparin as 1 #g/ml, and maximum migration activity occurred 
at concentrations of 10-50 #g/ml. Heparin at 50 #g/ml was equivalent to 100% mast 
cell CM. 
Biochemical Characterization.  The  endothelial  migration  activity  in  mast  cell  CM I xlO  s- 
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Fro.  3.  BCE cell proliferation in response  to mast cell CM.  10,000 cells were plated on 30-mm 
tissue culture dishes and incubated in DMEM 10% CS alone (A) or diluted 1:2 with mast cell CM 
(O) or Sarcoma 180 CM (O). The media was changed every 48 h for 10 d. Cells were harvested on 
days 7 and  10. Each point represents  the mean of three samples  +  SEM. 
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Fro.  4.  The inhibition of serum-stimulated DNA synthesis in 3T3 cells by mast cell CM. Growth- 
arrested  3T3  cells  in  serum-depleted  DMEM  were  labeled  for  72  h  with  [3H]thymidine.  Test 
conditions: calf serum alone (F-I), mast cell CM with serum (R) and without serum (m). 
was not  dialyzable through  cellulose with 6,000-8,000  mol wt cutoff. Furthermore, 
the activity was heat stable to  100°C.  Sonicated mast cells (10S/ml DMEM  10% CS) 
resulted  in  activity equivalent  to  medium  conditioned  by  the same number  of mast 
cells for 36 h. The capillary endothelial cell migration stimulating activity of sonicated 
mast  cell  preparations  was  not  decreased  after  incubation  with  Enzite  protease  or 
immobilized  trypsin  before  the  addition  of calf serum  (Fig.  6a).  Before  using  these 
enzymes,  their effective proteolytic  activity was  determined  by  measurement  of the 
liberation  of  protein-bound  [3H]lysine  from  3T3  cells  prelabeled  with  [ZH]lysine. R.  AZIZKHAN, J.  AZIZKHAN,  B.  ZETTER,  AND J.  FOLKMAN 
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FIc.  5.  The effect of isolated mast cell products on BCE migration. The mast cell products were 
solubilized in DMEM  10% CS and tested at log-dose intervals from  10 ng to  1 mg/ml. The mast 
cell products tested included: heparin (0), chondroitin sulfate ABC (i), ECF-A (I7), and histamine 
phosphate (&). Each point represents the mean area of 100 phagokinetic tracks ±  SEM. 
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FiG.  6.  The effect of proteolytic enzymes on the migration stimulating activity of mast cell lysates. 
(a)  DMEM  10% CS alone, lysates of 2 ×  10  t  mast cells suspended in DMEM  10% CS were tested 
for migration-stimulating activity after a  4-h incubation with 50 #g/ml Enzite protease (m) or 25 
mg/ml Enzite trypsin (g) or in the absence of enzymes (I-1). Each bar represents the mean area of 
100 phagokinetic tracks +  SEM. (b) Proteolytic activity of the immobilized enzymes was assayed by 
measuring release of TCA-precipitable  [aH]lysine from prelabeled  3T3 cell lysates as described in 
Materials and  Methods, The 3T3 cell  lysates were  incubated at  37°C  for 4  h  in the absence of 
enzymes (F1),  or in  the presence of .50  mg/ml Enzite  protease  (I),  or 2.5  mg/ml Enzite trypsin 
([]). 
Treatment with immobilized protease released >90% of the incorporated [aH]lysine, 
whereas the immobilized trypsin released 33% (Fig. 6b). 
To confirm that heparin is the migration factor in mast cell CM, specific inhibitors 
of heparin--protamine and heparinase--were studied separately. In a dose-dependent 
manner, protamine sulfate blocked the effect of mast cell CM on capillary endothelial 
cell migration, whereas the same concentrations of protamine sulfate in DMEM 10% 
CS had no effect on migration (Fig. 7 a). Furthermore, a  ratio of protamine sulfate: 
heparin  of 2:1  was  found  to  completely  neutralize  the  heparin-stimulated  BCE 
migration activity (Fig. 8). Protamine sulfate did not inhibit the capillary endothelial 
cell migration that was stimulated by sarcoma 180 CM (Fig. 7 b). 
Heparinase is known to degrade heparin (as well as chondroitin sulfates A, B, and 
C and heparan sulfate) (22). When mast cell CM or DMEM with heparin (50 #g/ml) 938  CAPILLARY ENDOTttELIAL CELL  MIGRATION 
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Fu3.  7.  The effect of protamine sulfate on mast cell-stimulated BCE  migration. (a)  Protamine 
sulfate, at concentrations from  100 ng to 200 #g/ml, was added to capillary endothelial cells plated 
on gold-coated cover slips and incubated in DMEM 10% CS (0) or in the same medium conditioned 
by mast cells (0). (b) DMEM 10% CS and the same medium conditioned by sarcoma 180 cells was 
added to BCE cells with (1~!)  and without (r-l) protamine sulfate (200 #g/ml). Each point represents 
the mean area of 100 phagokinetic tracks ±  SEM. 
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Fro.  8.  The effect of protamine sulfate on heparin-induced BCE  migration. BCE  migration in 
response to heparin (O) is compared with migration in response to heparin and protamine sulfate 
together  (0). Twice the amount of protamine sulfate was used to neutralize the activity of heparin. 
Protamine sulfate alone had no significant effect on migration. Each point represents the mean area 
of 100 phagokinetic tracks ± SEM. 
was incubated with heparinase before incubation with capillary endothelial cells, no 
increased migration occurred. In contrast, sarcoma 180 CM incubated with heparinase 
stimulated migration of these cells  (P <  0.05)  (Fig. 9). The specificity of heparinase 
was  tested  by using chondroitinase ABC, which  hydrolyzes chondroitin sulfates but 
not  heparin  (23).  Chondroitinase  ABC  was  found  not  to  alter  mast  cell  CM-  or 
heparin-stimulated migration (P___ 0.01)  (Fig.  10). 
Specificity of Heparin on Cell Migration.  To control for possible nonspecific migration 
activity  of  heparin,  bovine  aortic  endothelial  cells,  canine  kidney  (MDCK)  cells, 
human  fibroblasts,  and  Swiss  3T3  cells  were  exposed  to  heparin  in  concentrations 
from  10 ng to  1 mg/ml  (Fig.  11 a  and b). No increased migration was observed in any 
cell line, and inhibition of Swiss 3T3 cell migration was observed at concentrations of 
heparin >0.1  btg/ml (Fig.  11 b). R.  AZIZKHAN, J.  AZIZKHAN, B.  ZETTER,  AND J.  FOLKMAN  939 
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Fic.  9.  The effect of heparinase on heparin-stimulated and tumor-stimulated BCE migration. Test 
media included: DMEM  10% CS alone, DMEM 10% CS in the presence  of heparin (50 #g/ml), or 
DMEM 10% CS diluted  1:2 with sarcoma  180 CM or mast cell CM. Each media was tested in the 
presence  ([]) or absence  (l--l) of heparinase. The area of the phagokinetic tracks was measured after 
18 h. Each bar represents  the mean area of 100 migration tracks  :t: SEM. 
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Fio.  10.  The effect ofchondroitinase ABC on heparin- and tumor-stimulated BCE migration. Test 
media included DMEM 10% CS alone, DMEM 10% CS supplemented with heparin (50 #g/ml), or 
DMEM 113% CS diluted  1:2 with sarcoma 180 CM or mast cell CM. Each media was tested in the 
presence  ~(~,) or absence (1"1) of chondroitinase ABC (0.5 p.g/ml). E~tch bar represents  the mean area 
of 100 migration tracks  :t: SEM. 
Effect of Other Polyan,onic Substances on Migration.  Heparin  was then compared  with 
heparan  sulfate  in  the  capillary  endothelial  cell  migration  assay.  Heparan  sulfate 
stimulated  a  maximum  increase in migration of 15-25%  above control  (DMEM  10% 
CS)  at  a  concentration  of  100  /~g/ml  (Fig.  12).  This  result  was  not  statistically 
significant  at  any  concentration.  Furthermore,  all  the  major polyanionic  GAG  were 
simultaneously  compared  in  the  migration  assay  (Fig.  12).  Neither  nonsulfated 
hyaluronic acid, nor sulfated GAG, the ehondroitin sulfates A, B, and C, nor heparan 940  CAPILLARY ENDOTHELIAL CELL MIGRATION 
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FtG.  12.  The effect of GAG on the migration of BCE. Concentrations of GAG ranging from I0 ng 
to  1 mg/ml were  tested  in  the phagokinetic track  assay described  in  the  legend  to  Fig.  1.  Test 
substances: heparin  (O),  heparan  sulfate  (O),  chondroitin  sulfate  B  (I),  chondroitin  sulfate C 
(r-l),  hyaluronic acid (A), and keratan sulfate (A). Test substances were added in DMEM  10% CS. 
The controls included: DMEM  10% CS without additives (open bar) and sarcoma 180 CM (hatched 
bar). Each point represents the mean area of 100 phagokinetic tracks +  SEM. 
sulfate had any significant effect on capillary endothelial  cell migration  (P ~  0.05). 
Keratan  sulfate,  however,  inhibited  migration  of these  cells.  Finally,  the  effect  of 
synthetic  polyanions  on  migration  was  investigated.  Nonsulfated  dextran  of two R.  AZIZKHAN, J.  AZIZKHAN,  B.  ZETTER, AND J.  FOLKMAN  941 
different molecular weights (40,000 and 500,000) did not stimulate capillary endothe- 
lial cell migration. However, dextran sulfates of similar molecular weights significantly 
increased migration  (P <  0.01)  (Fig.  13). 
Discussion 
These experiments show that mast cells release a factor that stimulates the migration 
of BCE in vitro. This factor, which is found in mast cell CM and in lysates of isolated 
mast cells,  is heparin  on the basis of the following data:  (a)  only heparin,  of all  the 
mast cell secretory products tested, stimulated  capillary endothelial  cell migration in 
vitro; (b) heparin preparations from a variety of sources stimulated capillary endothe- 
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F~c. 13.  The effect of dextran  and dextran  sulfate on BCE migration.  Using the phagokinetic 
track assay, the migration of BCE in response to sulfated and nonsulfated synthetic polysaccharides 
was examined. Test substances were dissolved in DMEM 10% CS and included: dextran 40,000 mol 
wt (40); dextran sulfate 40,000 tool wt (40); dextran 500,000 tool wt (500); dextran sulfate 500,000 
tool wt (500). The concentration of polysaccharide was 10/~g/ml for each sample. Controls included: 
DMEM  10% CS and DMEM  10% CS supplemented with heparin (10 #g/ml). Each bar represents 
the mean area of 100 phagokinetic tracks + SEM. 
lial cell migration to the same degree but did not stimulate migration of several other 
cell  types;  (c)  the  migration  activity of heparin  and  mast  cell  CM  was blocked  by 
specific antagonists of heparin (protamine and heparinase)  but not by chondroitinase 
ABC;  (d)  the migration  activity of mast cell  CM was resistant  to heat  (100°C)  and 
incubation with Enzite protease and trypsin. Commercial heparin is also heat stable 
(24)  and rat  mast cell heparin  has been shown to be resistant  to proteolytic enzyme 
digestion  (25). 
Neither  mast  cell  CM  nor  heparin  stimulate  the  migration  of aortic endothelial 
cells  and  several  nonendothelial  cell  types.  Whereas  a  variety  of transformed  and 
neoplastic cells have been shown to produce migration factors for capillary endothelial 
cells  (13),  mast cells are the  first  nontransformed  cell  type found to produce such a 
factor. 
Although tumor CM and mast cell CM stimulate capillary endothelial cell migra- 
tion to comparable levels, they differ in one important respect. Tumor CM stimulates 
capillary endothelial  cell proliferation  as well as migration.  Mast cell CM stimulates 942  CAPILLARY ENDOTHELIAL CELL MIGRATION 
migration only. Thus, endothelial cell migration and proliferation can be uncoupled 
in vitro. Although our results cannot predict whether separate factors will regulate 
migration and proliferation in vivo, they raise the possibility that these two events are 
controlled independently, and that the migration component of neovascularization 
may be modulated by the action of mast cell products. 
The  mechanism  by which  capillary endothelial cell  migration  is  stimulated by 
heparin is unknown. Although heparin is a  densely charged GAG, polyanions with 
similar charge densities, such as heparan sulfate and the chondroitin sulfates (24), do 
not significantly alter cell motility. Furthermore, keratan sulfate, a charged sulfated 
GAG  found  in  large  quantities  in  avascular  tissues  like  the  cornea  and  cartilage, 
inhibits  capillary  endothelial  cell  migration.  Heparin  is  more  sulfated  than  the 
structurally related GAG (24),  heparan sulfate and hyaluronic acid. The synthetic 
polyanion, dextran sulfate, stimulates capillary endothelial cell migration; however, 
nonsulfated dextran does not. Although both charge and degree of sulfation may be 
important  in stimulating migration of capillary endothelial cells, these parameters 
alone do not account for the phenomenon observed. 
In other cell systems, cell membrane-heparin interactions have been associated with 
increased cell membrane motility. Heparin has been implicated in both phagocytosis 
by  Kupffer  cells  (26,  27)  and  in  pinocytosis  by  murine  macrophages  (28)  and 
fibroblasts (29).  Heparin also increases pseudopod formation and motility of Amoeba 
proteus (29). Recently, arterial smooth muscle cell proliferation (30, 31) has been shown 
to be inhibited by heparin. 
The ability to stimulate migration of capillary endothelial cells in vitro is a newly 
discovered property of mast cells and heparin.  It is not known if this activity also 
functions in vivo and, if so, for what reason. However, it is known that mast cells are 
intimately associated with tumor angiogenesis (4)  (and possibly with other forms of 
angiogenesis). Therefore, it is theoretically possible that one role of mast cells is to 
enhance the directional elongation of new capillary sprouts by sustained release of 
heparin. If these observations are upheld by experiments in vivo, one possible type of 
angiogenesis inhibitor would be a  substance that  would block the endothelial cell 
migration effect of mast cells. 
Summary 
Migration of capillary endothelial cells is an important component of angiogenesis 
in vivo. Increased numbers of mast cells have been associated with several types of 
angiogenesis. We have used a  quantitative assay in vitro to demonstrate that mast 
cells  release  a  factor  that  significantly increases  bovine  capillary  endothelial  cell 
migration. The factor is present in medium conditioned by mast cells as well as lysates 
of mast cells. The stimulatory effect of mast cells on migration is specific for capillary 
endothelial cells.  Furthermore,  mast  cells have  no  mitogenic activity for capillary 
endothelial cells. 
Of all the secretory products of mast cells tested, only heparin stimulated capillary 
endothelial cell migration in vitrol  Heparin preparations  from a  variety of sources 
stimulated  capillary  endothelial  cell  migration  to  the  same  degree  but  did  not 
stimulate migration of several other cell types. The migration activity of heparin and 
mast cell conditioned medium was blocked by specific antagonists of heparin (prota- 
mine and heparinase),  but  not  by chondroitinase ABC. The  migration activity of R.  AZIZKHAN, J.  AZIZKHAN,  B.  ZETTER, AND J.  FOLKMAN  943 
mast  cell  conditioned  medium  was  resistant  to  heat  (100°C)  and  incubation  with 
proteolytic enzymes. These results suggest that the role of mast cells in angiogenesis 
may be to enhance migration of the endothelial cells of growing capillaries. 
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